Downregulation of Dicer enhances tumor cell proliferation and invasion

International Journal of Oncology

Volumn 37, Issue 2, 2010, Pages 299-305

  Han, Lei ^a,b   Zhang, Anling ^a,b   Zhou, Xuan ^a,b   Xu, Peng ^a   Wang, Guang Xiu ^a   Pu, Pei Yu ^a,b   Kang, Chun Sheng ^a,b,c  

^a Tianjin Neurological Institute   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c Variation and Regeneration   (China)

Author keywords

AKT; Cancer; Dicer; Invasion; Proliferation

Indexed keywords

CYCLIN A; CYCLINE; DICER; GELATINASE A; GELATINASE B; MICRORNA; SHORT HAIRPIN RNA; RIBONUCLEASE III; SMALL INTERFERING RNA;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GENE THERAPY; CANCER INVASION; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBCUTANEOUS TISSUE TUMOR; TUMOR CELL; TUMOR CELL LINE; TUMOR GROWTH; VIRUS RECOMBINANT; XENOGRAFT; ANIMAL; BAGG ALBINO MOUSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; FEMALE; GENE THERAPY; GENETIC TRANSFECTION; GENETICS; METABOLISM; NEOPLASM; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; TUMOR CELL CULTURE;

ANIMALS; CELL PROLIFERATION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASMS; RIBONUCLEASE III; RNA, SMALL INTERFERING; TRANSFECTION; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77954154971     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000678     Document Type: Article

References (29)

1. Ouellet DL, Perron MP, Gobeil LA, Plante P and Provost P: MicroRNAs in gene regulation: when the smallest governs it all. J Biomed Biotech 2006: 1-20, 2006.
2. Lu J, Getz G, Miska EA, et al: MicroRNA expression profiles classify human cancers. Nature 435: 834-838, 2005.
3. Karube Y, Tanaka H, Osada H, et al: Reduced expression of Dicer associated with poor prognosis in lung cancer patients. Cancer Sci 96: 111-115, 2005.
4. Michael MZ, O'Connor SM, Van Holst PG, Yong GP and James RJ: Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 1: 882-891, 2003.
5. Calin GA, Dumitru CD, Shimizu M, et al: Frequent deletions and down-regulation of micro-RNA genes miR-15 and miR-16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 99: 15524-15529, 2002.
6. Takamizawa J, Konishi H, Yanagisawa K, et al: Reduced expression of the let-7 microRNA in human lung cancers in association with shortened postoperative survival. Cancer Res 64: 3753-3756, 2004.
7. He L, Thomson JM, Hemann MT, et al: A microRNA polycistron as a potential human oncogene. Nature 43: 828-833, 2005.
8. Hayashita Y, Osada H, Tatematsu Y, et al: A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65: 9628-9632, 2005. (Pubitemid 41541436)
9. Chan JA, Krichevsky AM and Kosik KS: MicroRNA-21 is an anti-apoptotic factor in human glioblastoma cells. Cancer Res 65: 6029-6033, 2005. (Pubitemid 40994386)
10. Carmell MA and Hannon GJ: RNase III enzymes and the initiation of gene silencing. Nat Struct Mol Biol 11: 214-218, 2004.
11. Yi R, Qin Y, Macara IG and Cullen BR: Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 17: 3011-3016, 2003. (Pubitemid 38040764)
12. Grishok A, Pasquinelli AE, Conte D, et al: Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing. Cell 106: 23-34, 2001.
13. Hutvagner G, McLachlan J, Pasquinelli AE, Balint E, Tuschl T and Zamore PD: A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293: 834-838, 2001. (Pubitemid 32743968)
14. Kanellopoulou C, Muljo SA, Kung AL, et al: Dicer-deficient mouse embryonic stem cells are defective in differentiation and centromeric silencing. Genes Dev 19: 489-501, 2005. (Pubitemid 40256280)
15. Harfe BD, McManus MT, Mansfield JH, Hornstein E and Tabin CJ: The RNase III enzyme Dicer is required for morphogenesis but not patterning of the vertebrate limb. Proc Natl Acad Sci USA 102: 10898-10903, 2005.
16. Muljo, SA, Ansel KM, Kanellopoulou C, Livingston DM, Rao A and Aberrant KR: T cell differentiation in the absence of Dicer. J Exp Med 202: 261-269, 2005.
17. Kumar MS, Lu J, Mercer KL, Golub TR and Jacks T: Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 39: 673-677, 2007. (Pubitemid 46676103)
18. Chiosea S, Jelezcova E, Chandran U, Acquafondata M, McHale T, Soboland RW and Dhir R: Up-regulation of Dicer, a component of the microRNA machinery, in prostate adenocarcinoma. Am J Pathol 169: 1812-1820, 2006.
19. Pu PY, Kang CS, Zhang ZY, Liu XZ and Jiang H: Down-regulation of PIK3CB by siRNA suppresses malignant glioma cell growth in vitro and in vivo. Technol Cancer Res Treat 5: 271-280, 2006. (Pubitemid 43946260)
20. Doi N, Zenno S, Ueda R, Ohki-Hamazaki H, Ui-Tei K and Saigo K: Short-interfering-RNA-mediated gene silencing in mammalian cells requires Dicer and eIF2C translation initiation factors. Curr Bio 13: 41-46, 2003. (Pubitemid 36080621)
21. Vivanco I and CL Sawyers: The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer 2: 489-501, 2002. (Pubitemid 37328931)
22. Krek W, Ewen ME, Shirodkar S, Arany Z, Kaelin WG and Livingston DM: Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell 78: 161-172, 1994. (Pubitemid 24228310)
23. Lees E, Faha B, Dulic V, Herd SI and Harlow E: Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner. Genes Dev 6: 1874-1885, 1992.
24. Wang J, Chenivesse X, Henglein B and Brechot C: Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma. Nature 343: 555-557, 1990. (Pubitemid 20042714)
25. Barlat I, Fesquet D, Strausfeld U, Brechot C, Henglein B, Vie A and Blanchard JM: Loss of the G 1-S control of cyclin A expression during tumoral progression of Chinese hamster lung fibroblasts. Cell Growth Differ 4: 105-113, 1993.
26. Karagiannis ED and Popel AS: Distinct modes of collagen type I proteolysis by matrix metalloproteinase (MMP) 2 and membrane type I MMP during the migration of a tip endothelial cell: Insights from a computational model. J Theor Biol 238: 124-145, 2005.
27. Stetler-Stevenson WG: The role of matrix metalloproteinases in tumor invasion, metastasis and angiogenesis. Surg Oncol Clin N Am 10: 383-392, 2001.
28. Suzuki A, Lu J, Kusakai G, Kishimoto A, Ogura T and Esumi H: ARK5 is a tumor invasion-associated factor downstream of Akt signaling. Mol Cell Biol 24: 3526-3535, 2004. (Pubitemid 38452091)
29. Thant AA, Nawa A, Kikkawa F, et al: Fibronectin activates matrix metalloproteinase-9 secretion via the MEK1-MAPK and the PI3K-Akt pathways in ovarian cancer cells. Clin Exp Metastasis 18: 423-428, 2000. (Pubitemid 32588623)